Lamisilate Monodose

Terbinafine Hydrochloride, the active ingredient in Lamisilate Monodose, is an allylamine presented as a topical formulation for skin application. It is indicated for the treatment of superficial fungal infections of the skin and nails in both adults and children, acting by disrupting fungal cell membrane synthesis.

GNH USA supplies Lamisilate Monodose as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing consistent quality and regulatory adherence for global distribution and supporting timely delivery to meet patient care needs.

Terbinafine Hydrochloride is an allylamine antifungal used to treat dermatophyte and yeast infections of the skin and nails.

- Tinea pedis: relief of itching and eradication of the causative dermatophyte on the feet. - Tinea corporis: clearance of ring‑shaped lesions on the body. - Tinea cruris: treatment of fungal infection in the groin area. - Tinea versicolor: reduction of discolored patches caused by Malassezia species. - Onychomycosis (topical): improvement of fungal nail infection when applied to the affected nail surface.

Terbinafine Hydrochloride may cause local skin reactions when applied topically.

Common Side Effects: - Itching: mild to moderate sensation at the application site. - Burning: transient heat sensation during or after application. - Redness: localized erythema around the treated area. - Scaling: flaking of skin as the infection resolves. - Dryness: temporary loss of skin moisture. - Irritation: mild discomfort or stinging.

Serious or Rare Side Effects: - Allergic reaction: hives, swelling, or difficulty breathing. - Severe skin rash: widespread redness or blistering. - Contact dermatitis: persistent inflammation at the site. - Swelling: localized edema beyond normal irritation. - Urticaria: raised, itchy welts on the skin. - Rare systemic effects: liver enzyme abnormalities with extensive use.

Before using Lamisilate Monodose, consider the following precautions.

- Avoid use on broken skin: do not apply to open wounds or erosions. - Do not apply to mucous membranes: keep away from eyes, mouth and genital mucosa. - Check for hypersensitivity: discontinue if signs of allergic reaction appear. - Consult healthcare professional if using other topical agents: avoid overlapping applications that may increase irritation. - Store at room temperature: keep in the original pack, protect from moisture and light.

Terbinafine Hydrochloride may interact with other medications or products.

Major Interactions (Avoid): - Systemic terbinafine: concurrent use may increase overall exposure and risk of systemic side effects. - Known hypersensitivity to allylamines: avoid to prevent severe allergic reactions.

Moderate Interactions (Monitor Closely): - Other topical antifungals: may increase local irritation. - Corticosteroid creams: can mask infection signs and delay healing. - Alcohol‑based skin products: may enhance skin dryness and irritation. - Phototoxic agents: increase risk of photosensitivity when exposed to sunlight.